Subtype
Uterine Neoplasm
CI-CAN-00004208Explore in graph →
Non-malignant925 active trials7 approved drugs44 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00004208Explore in graph →
Clinical trials
3,823 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05035173 | The LYSA (Linking You to Support and Advice) Trial(LYSA) | completed | N/A | 200 | University College CorkOTHER | 1 | Mar 4, 2026 | clinicaltrials |
| NCT04697628 | Tisotumab Vedotin vs Chemotherapy in Recurrent or Metastatic Cervical Cancer(innovaTV 301) | completed | Phase 3 | 502 | Seagen, a wholly owned subsidiary of PfizerINDUSTRY | 25 | Feb 24, 2026 |
| clinicaltrials |
| NCT03005743 | Image Based Brachytherapy in Locally Advanced Cervical Cancers - a Randomized Controlled Trial(COMBAT-Cx) | completed | N/A | 1,050 | Tata Memorial HospitalOTHER_GOV | 1 | Feb 23, 2026 | clinicaltrials |
| NCT04221945 | Study of Chemoradiotherapy With or Without Pembrolizumab (MK-3475) For The Treatment of Locally Advanced Cervical Cancer (MK-3475-A18/KEYNOTE-A18/ENGOT-cx11/GOG-3047) | completed | Phase 3 | 1,060 | Merck Sharp & Dohme LLCINDUSTRY | 30 | Feb 20, 2026 | clinicaltrials |
| NCT05870787 | iMproving thE DIagnostics And Treatment Of ceRvical Precancer(MEDIATOR) | completed | — | 929 | University of AarhusOTHER | 1 | Feb 10, 2026 | clinicaltrials |
| NCT02749110 | Participation in Screening for Cervical Cancer: Interest of a Self-sampling Device Provided by the General Practitioner(PaCUDAHL-Gé) | completed | N/A | 308 | University Hospital, LilleOTHER | 1 | Feb 5, 2026 | clinicaltrials |
| NCT03635567 | Efficacy and Safety Study of First-line Treatment With Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Women With Persistent, Recurrent, or Metastatic Cervical Cancer (MK-3475-826/KEYNOTE-826) | completed | Phase 3 | 617 | Merck Sharp & Dohme LLCINDUSTRY | 19 | Feb 4, 2026 | clinicaltrials |
| NCT06662136 | The Effect of Motivational Interviewing on HPV-DNA Testing | completed | N/A | 90 | Muazez küçükkayaOTHER | 1 | Feb 3, 2026 | clinicaltrials |
| NCT07384468 | Ultrasound-Guided Stellate Ganglion Block Plus Propofol for Perimenopausal Insomnia With Anxiety(SGB-PROP-PIA) | completed | N/A | 233 | Xiaochen JiOTHER | 1 | Feb 3, 2026 | clinicaltrials |
| NCT03884101 | Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) Versus Chemotherapy for Endometrial Carcinoma (ENGOT-en9 / MK-7902-001)(LEAP-001) | completed | Phase 3 | 842 | Merck Sharp & Dohme LLCINDUSTRY | 22 | Feb 2, 2026 | clinicaltrials |
| NCT07365969 | Risk of Hysterectomy at Time of Myomectomy | completed | — | 293 | Ain Shams UniversityOTHER | 1 | Jan 30, 2026 | clinicaltrials |
| NCT03284866 | HPV Vaccine Therapy in Reducing High-Grade Cervical Lesions in Patients With HIV and HPV(COVENANT) | completed | Phase 3 | 536 | AIDS Malignancy ConsortiumNETWORK | 5 | Jan 28, 2026 | clinicaltrials |
| NCT06474065 | Pregnancy Outcomes Following Myomectomy | completed | — | 150 | Centro di Ricerca Clinica SalentinoNETWORK | 1 | Jan 23, 2026 | clinicaltrials |
| NCT03578406 | HPV-E6-Specific Anti-PD1 TCR-T Cells in the Treatment of HPV-Positive NHSCC or Cervical Cancer | completed | Phase 1 | 9 | Xinqiao Hospital of ChongqingOTHER | 1 | Jan 21, 2026 | clinicaltrials |
| NCT07244315 | Cervical Cancer Screening of Postmenopausal Women in Low- and Middle-income Countries Using HPV Self-sampling and Triage by Genotyping and Cytology | completed | — | 500 | University Hospital, GenevaOTHER | 1 | Jan 21, 2026 | clinicaltrials |
| NCT07250178 | ONSD as an ICP Marker in vNOTES and TLH | completed | N/A | 66 | Saglik Bilimleri Universitesi Gazi Yasargil Training and Research HospitalOTHER | 1 | Jan 7, 2026 | clinicaltrials |
| NCT06429163 | Pre-incisional Wound INfiltration and Hypogastric PLEXus Block Using Ropivacaine in Laparoscopic Myomectomy(WINPLEX) | completed | N/A | 207 | Saint Petersburg State University, RussiaOTHER | 1 | Jan 6, 2026 | clinicaltrials |
| NCT06839378 | Flura-seq for Evaluating the Effects of Different Hyperthermic Intraperitoneal Chemotherapy Regimens on the Transcriptome of Pseudomyxoma Peritonei | completed | N/A | 36 | Beijing Tsinghua Chang Gung HospitalOTHER | 1 | Jan 6, 2026 | clinicaltrials |
| NCT00980954 | Chemotherapy and Pelvic Radiation Therapy With or Without Additional Chemotherapy in Treating Patients With High-Risk Early-Stage Cervical Cancer After Radical Hysterectomy | completed | Phase 3 | 236 | Radiation Therapy Oncology GroupNETWORK | 4 | Dec 31, 2025 | clinicaltrials |
| NCT07306195 | Comparison Between High and Low Level Para-aortic Lymphadenectomy in High and Intermediate Risk Endometrial Carcinoma | completed | N/A | 150 | Ahmed AoufOTHER | 1 | Dec 29, 2025 | clinicaltrials |
| NCT06846099 | A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Efficacy and Indications of RP903 | completed | Phase 1 | 69 | Risen (Suzhou) Pharma Tech Co., Ltd.INDUSTRY | 1 | Dec 23, 2025 | clinicaltrials |
| NCT03027479 | Skeletal Muscle Energy Metabolism in Women With Weight Loss and Ovarian and/or Endometrial Cancer With Weight Loss(METERMUS-IMC) | completed | N/A | 70 | University Hospital, ToursOTHER | 1 | Dec 22, 2025 | clinicaltrials |
| NCT01639820 | Comparison of Pelvic Lymphadenectomy Versus Isolated Sentinel Lymph Node Biopsy Procedure for Early Stages of Cervical Cancers : a Multicenter Study With Evaluation of Medico-economic Impacts(SENTICOL2) | completed | N/A | 267 | Hospices Civils de LyonOTHER | 1 | Dec 19, 2025 | clinicaltrials |
| NCT03466788 | Impact of Adjuvant Chemotherapy on the Quality of Life of Patients Treated for Stage II / III Endometrial Cancer(EndoQOL) | completed | N/A | 51 | Centre Francois BaclesseOTHER | 1 | Dec 18, 2025 | clinicaltrials |
| NCT04458402 | Adjuvant Hypofractionated Whole Pelvis Radiation Therapy in Endometrial Cancer | completed | N/A | 8 | Teresa MeierOTHER | 1 | Dec 18, 2025 | clinicaltrials |
| NCT07046949 | Anterior Quadratus Lumborum Block as a Component of Multimodal Analgesia for Abdominal Hysterectomies | completed | N/A | 56 | Yuri Semenyuk Rivne Regional Clinical HospitalOTHER | 1 | Dec 16, 2025 | clinicaltrials |
| NCT04157985 | Evaluating Length of Treatment With PD-1/PD-L1 Inhibitor in Advanced Solid Tumors | completed | Phase 3 | 161 | Dan ZandbergOTHER | 1 | Dec 11, 2025 | clinicaltrials |
| NCT04501913 | Remote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported Outcomes | completed | — | 22 | City of Hope Medical CenterOTHER | 1 | Dec 5, 2025 | clinicaltrials |
| NCT06007586 | Prevention and Treatment of CINV Caused by TC Regimen in Gynecological Malignant Tumor Patients | completed | Phase 3 | 143 | Sichuan Cancer Hospital and Research InstituteOTHER | 1 | Dec 4, 2025 | clinicaltrials |
| NCT06768086 | Preoperative Administration of EGCG, Vitamin D and DCI Prior Hysteroscopic Myomectomy(PREHYSMYOM) | completed | — | 90 | Centro di Ricerca Clinica SalentinoNETWORK | 1 | Dec 4, 2025 | clinicaltrials |
| NCT04865289 | Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) Versus Chemotherapy for Endometrial Carcinoma (ENGOT-en9 / MK-7902-001) - China Extension Study(LEAP-001) | completed | Phase 3 | 130 | Merck Sharp & Dohme LLCINDUSTRY | 1 | Dec 2, 2025 | clinicaltrials |
| NCT07250841 | Cervical Intraepithelial Neoplasia Screening Using Liquid-Based Pap Smear Among Egyptian Women | completed | — | 984 | Kasr El Aini HospitalOTHER | 1 | Nov 28, 2025 | clinicaltrials |
| NCT05795595 | A Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With Relapsed or Refractory Solid Tumors | completed | Phase 1 / Phase 2 | 19 | CRISPR Therapeutics AGINDUSTRY | 1 | Nov 26, 2025 | clinicaltrials |
| NCT05445167 | A Clinical Study of KLH-2109 in Uterine Fibroids Patient With Menorrhagia and Pain | completed | Phase 3 | 89 | Kissei Pharmaceutical Co., Ltd.INDUSTRY | 1 | Nov 25, 2025 | clinicaltrials |
| NCT00957411 | Radiation Therapy and Cisplatin With or Without Cetuximab in Treating Patients With Stage IB, Stage II, or Stage IIIB Cervical Cancer(CETUXICOL) | completed | Phase 2 | 76 | Institut CurieOTHER | 1 | Nov 24, 2025 | clinicaltrials |
| NCT07210918 | Serum Trace Element Levels in Some Gynecological Diseases | completed | N/A | 40 | Cumhuriyet UniversityOTHER | 1 | Nov 24, 2025 | clinicaltrials |
| NCT05255393 | Survey on Lymphedema After Sentinel Lymph Node Biopsy in People With Cervical or Vulvar Cancer | completed | — | 111 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Nov 21, 2025 | clinicaltrials |
| NCT06534008 | Strive Cardio for Endometrial Cancer Survivors | completed | N/A | 33 | Jess S. GorzelitzOTHER | 1 | Nov 20, 2025 | clinicaltrials |
| NCT05509413 | DEFLAGYN® Vaginal Gel and Spontaneous Remission and Regression of Unclear Cervical Smears and HPV High-risk Infections(HPV-VG1) | completed | N/A | 242 | Ruhr University of BochumOTHER | 1 | Nov 18, 2025 | clinicaltrials |
| NCT05383482 | Afuresertib +Sintilimab+Chemotherapy in Patients With Selected Solid Tumors That Resistance to Prior Anti-PD-1/PD-L1 | completed | Phase 1 / Phase 2 | 22 | Laekna LimitedINDUSTRY | 1 | Nov 17, 2025 | clinicaltrials |
| NCT06925113 | A Study to Investigate the Prevalence of Human Epidermal Growth Factor Receptor 2 (HER2) Immunohistochemistry (IHC) 3+ and Characterize the Clinicopathologic Features of Gynecologic Cancers in Taiwan(HERGYN) | completed | — | 509 | Daiichi SankyoINDUSTRY | 1 | Nov 17, 2025 | clinicaltrials |
| NCT03738228 | Atezolizumab Before and/or With Chemoradiotherapy in Immune System Activation in Patients With Node Positive Stage IB2, II, IIIB, or IVA Cervical Cancer | completed | Phase 1 | 40 | National Cancer Institute (NCI)NIH | 1 | Nov 12, 2025 | clinicaltrials |
| NCT04272086 | Utility of Liposomal Bupivacaine Transversus Abdominal Plane Block for Open Myomectomy | completed | Phase 4 | 140 | Icahn School of Medicine at Mount SinaiOTHER | 1 | Nov 12, 2025 | clinicaltrials |
| NCT01676818 | Eribulin Mesylate in Treating Patients With Advanced or Recurrent Cervical Cancer | completed | Phase 2 | 32 | University of Southern CaliforniaOTHER | 1 | Nov 6, 2025 | clinicaltrials |
| NCT02111941 | Vaccine Therapy for Patients With Stage IIIC-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer | completed | Early Phase 1 | 19 | Mayo ClinicOTHER | 1 | Oct 31, 2025 | clinicaltrials |
| NCT06861504 | The Femscope Calm Collect Device | completed | N/A | 13 | University of MichiganOTHER | 1 | Oct 27, 2025 | clinicaltrials |
| NCT06550791 | Evaluating the Anticancer Learning Circle Lifestyle Program in Endometrial Cancer Survivors | completed | N/A | 23 | University of VirginiaOTHER | 1 | Oct 24, 2025 | clinicaltrials |
| NCT03325634 | Stereotactic Body Radiation Therapy in Treating Patients With Recurrent Primary Ovarian or Uterine Cancer | completed | Phase 1 | 15 | University of Colorado, DenverOTHER | 1 | Oct 23, 2025 | clinicaltrials |
| NCT04049227 | Abemaciclib and Letrozole in Treating Patients With Endometrial Cancer | completed | Early Phase 1 | 27 | Northwestern UniversityOTHER | 1 | Oct 20, 2025 | clinicaltrials |
| NCT04386993 | De-escalated Conformal Radiation Expedited Sequentially With Chemotherapy for Endometrial Cancer(DeCRESCEndo) | completed | N/A | 25 | Washington University School of MedicineOTHER | 1 | Oct 20, 2025 | clinicaltrials |
Data updated 23 days agoSource updated Mar 4, 2026source: clinicaltrials